Breast cancer (BC) is the most common malignancy in women. In 2014, there were an estimated 3.3 million women living with BC in the United States. Its incidence represents 15% of all new cancer cases,
The aim of this study was to provide the first insight into the role of genetic variability of ABCC8, ABCD2, KIF14, SLCO1A2 and SLC46A1 in breast cancer prognosis and therapy outcome. Targeted sequenc
